• EN

Pill testing

Project manager: Gregor Burkhart

In order to respond to specific information needs emerging from the challenge of synthetic drugs, a specialised form of outreach work was analysed in a recent report on on-site pill testing interventions in the European Union - i.e. interventions which approach hard-to-reach groups in clubs and raves through the offer to analyse on the spot their pills (sold as 'ecstasy').

The Verein Wiener Sozialprojekte and CheckIt (Vienna) were contracted as leading organisations for an inventory project entitled 'On-site pill-testing interventions in the European Union', involving other pill-testing programmes such as DIMS (NL), Médécins du Monde (F), Modus Vivendi (B), Eve and Rave (D). The objectives, evaluation indicators, target groups, methodology, potential and pitfalls of ongoing projects were examined with a view to assessing how pill-testing projects can be used for harm-reduction and prevention purposes and how the information provided through the EMCDDA Joint action on new synthetic drugs can be channelled into daily demand-reduction practice.

The executive summary (42 KB), final report (380KB) and fact files (144KB) are available.

In 2002, the European Commission commissioned an evaluation study on the effectiveness of on-site pill testing interventions. A summary of the study outcomes is available as an EDDRA-entry.

Related documents
Inventory of on-site pill-testing interventions in the EU
EMCDDA, 2001
Executive summary
Download this attachment in PDF format
Final report
Download this attachment in PDF format
Fact files
Download this attachment in PDF format

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Tel. (351) 211 21 02 00

More contact options >>

Page last updated: Thursday, 30 March 2006